Diavantis is a young and aspiring medical technology start-up with a small but very interdisciplinary team located in Switzerland. We are a spin-off fully owned by Cendres+Métaux SA, one of the leading Swiss companies in the field of medical technology. Our current investigational device, Bone Anchored Port, is a long-term vascular access for haemodialysis. The port system consists of a titanium implant, a replaceable cover and a catheter. The novelty lies in its fixation to the head, for which the team won the Swiss Technology Award 2014 in the category "Sustainability Leader". At present, we are running a multicentre clinical investigation under the name of Bone Anchored Port - A novel vascular access for hemodialysis treatment which started at the University Hospital in Berne.
Diavantis is a young and aspiring medical technology start-up with a small but very interdisciplinary team located in Switzerland. We are a spin-off fully owned by Cendres+Métaux SA, one of the leading Swiss companies in the field of medical technology. Our current investigational device, Bone Anchored Port, is a long-term vascular access for haemodialysis. The port system consists of a titanium implant, a replaceable cover and a catheter. The novelty lies in its fixation to the head, for which the team won the Swiss Technology Award 2014 in the category "Sustainability Leader". At present, we are running a multicentre clinical investigation under the name of Bone Anchored Port - A novel vascular access for hemodialysis treatment which started at the University Hospital in Berne.